ACADIA Pharmaceuticals (ACAD) Q2 2014 Results - Earnings Call Webcast

Aug. 5.14 | About: ACADIA Pharmaceuticals (ACAD)

ACADIA Pharma (NASDAQ:ACAD): Q2 EPS of -$0.22 misses by $0.03. Revenue of $0.03M (-93.3% Y/Y) misses by $0.23M.

The following audio is from a conference call that will begin on August 05, 2014 at 17:00 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.